Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells

Cellular and Molecular Life Sciences

Volumn 65, Issue 17, 2008, Pages 2740-2751

  Lin, C I ^a   Chen, C N ^a,b,c   Huang, M T ^b   Lee, S J ^a   Lin, C H ^a   Chang, C C ^a   Lee, H ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c RESEARCH CENTER FOR APPLIED SCIENCES   (Taiwan)

Author keywords

Endothelial cells; LPA; Lymphangiogenesis; Lymphatic markers; VEGF C

Indexed keywords

BIOLOGICAL MARKER; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; PODOPLANIN; SMALL INTERFERING RNA; VASCULOTROPIN C; VASCULOTROPIN INHIBITOR;

ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PROTEIN EXPRESSION; UMBILICAL VEIN; UPREGULATION;

BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HOMEODOMAIN PROTEINS; HUMANS; INDOLES; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; MEMBRANE GLYCOPROTEINS; NAPHTHALENES; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VESICULAR TRANSPORT PROTEINS;

EID: 51349112099     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8314-9     Document Type: Article

References (51)

1. Eichholtz, T., Jalink, K., Fahrenfort, I. and Moolenaar, W. H. (1993) The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291, 677-680.
2. Moolenaar, W. H., Kranenburg, O., Postma, F. and Zondag, G. C. (1997) Lysophosphatidic acid: G-protein signalling and cellular responses. Curr. Opin. Cell. Biol. 9, 168-173.
3. Lee, H., Goetzl, E. J. and An, S. (2000) Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am. J. Physiol. Cell. Physiol. 278, C612-C618.
4. Panetti, T. S. (2002) Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. Biochim. Biophys. Acta 1582, 190-196.
5. Panetti, T. S., Chen, H., Misenheimer, T. M., Getzler, S. B. and Mosher, D. F. (1997) Endothelial cell mitogenesis induced by LPA: Inhibition by thrombospondin-1 and thrombospondin-2. J. Lab. Clin. Med. 129, 208-216.
6. Panetti, T. S., Nowlen, J. and Mosher, D. F. (2000) Sphingosine-1- phosphate and lysophosphatidic acid stimulate endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 20, 1013-1019.
7. Chen, S. U., Chou, C. H., Lee, H., Ho, C. H., Lin, C. W. and Yang, Y. S. (2008) Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and NF-kappaB-dependent pathways: Implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab. 93, 935-943.
8. Langlois, S., Gingras, D. and Beliveau, R. (2004) Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood 103, 3020-3028.
9. Wu, W. T., Chen, C.N., Lin, C. I., Chen, J. H. and Lee, H. (2005) Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 146, 3387-3400.
10. 3. Biochem. Biophys. Res. Commun. 363: 1001-1008.
11. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671-674.
12. Ryan, T. J., Mortimer, P. S. and Jones, R.L. (1986) Lymphatics of the skin. Int. J. Dermatol. 25, 411-419.
13. English, D., Kovala, A. T., Welch, Z., Harvey, K. A., Siddiqui, R. A. Brindley, D. N. and Garcia, J. G. (1999) Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J. Hematother. Stem. Cell. Res. 8, 627-634.
14. van Meeteren, L. A., Ruurs, P., Stortelers, C., Bouwman, P., van Rooijen, M. A., Pradere, J. P., Pettit, T. R., Wakelam, M. J., Saulnier-Blache, J. S., Mummery, C. L., Moolenaar, W. H. and Jonkers, J. (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 26, 5015-5022.
15. Makinen, T., Veikkola, T., Mustjoki, S., Karpanen, T., Catimel, B. and Nice, E. C. (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20, 4762-4773.
16. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K. and Detmar, M. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192-198.
17. Skobe, M., Hamberg, L.M., Hawighorst, T., Schirner, M., Wolf, G.L., Alitalo, K. and Detmar, M. (2001) Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159, 893-903.
18. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. and Alitalo, K. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290-298.
19. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N. and Alitalo, K. (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898-3911.
20. Lohela, M., Saaristo, A., Veikkola, T. and Alitalo, K. (2003) Lymphangiogenic growth factors, receptors and therapies. Thromb. Haemost. 90, 167-184.
21. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W. and Ullrich, A. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
22. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V. and Alitalo, K. (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122, 3829-3837.
23. Goldman, J., Rutkowski, J. M., Shields, J. D., Pasquier, M. C., Cui, Y., Schmokel, H. G., Willey, S., Hicklin, D. J., Pytowski, B. and Swartz, M. A. (2007) Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J. 21, 1003-1012.
24. Roberts, N., Kloos, B., Cassella, M., Podgrabinska, S., Persaud, K., Wu, Y., Pytowski, B. and Skobe, M. (2006) Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. 66, 2650-2657.
25. Hsieh, C. Y., Chen, C. A., Chou, C. H., Lai, K. P., Jeng, Y. M., Kuo, M. L., and Wei L. H. (2004) Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: Implications for malignant ascites formation and tumor lymphangiogenesis. J. Biomed. Sci.11, 249-259.
26. Su, J. L., Shih, J. Y., Yen, M. L., Jeng, Y. M., Chang, C. C., Hsieh, C. Y., Wei, L. H., Yang, P. C., and Kuo M. L. (2004) Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: A novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res. 64, 554-564.
27. Timoshenko, A. V., Chakraborty, C., Wagner, G. F. and Lala P. K. (2006) COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br. J. Cancer 94, 1154-1163.
28. O-charoenrat, P., Rhys-Evans, P., Modjtahedi, H. and Eccles, S. A. (2000) Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells. Clin. Exp. Metastasis 18, 155-161.
29. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D. and Prevo, R. (2001) Vascular endothelial growth factor-C mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672-682.
30. Oliver, G. (2004) Lymphatic vasculature development. Nat. Rev. Immunol. 4, 35-45.
31. Weninger, W., Partanen, T. A., Breiteneder-Geleff, S., Mayer, C., Kowalski, H., Mildner, M., Pammer, J., Stürzl, M., Kerjaschki, D., Alitalo, K. and Tschachler, E. (1999) Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Invest. 79, 243-251.
32. Wigle, J. T., Harvey, N., Detmar, M., Lagutina, I., Grosveld, G. and Gunn, M. D. (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21, 1505-1513.
33. Ji, R. C. (2006) Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 25, 677-694.
34. Hu, Y. L., Albanese, C., Pestell, R. G. and Jaffe, R. B. (2003) Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J. Natl. Cancer Inst. 95, 733-740.
35. Groger, M., Loewe, R., Holnthoner, W., Embacher, R., Pillinger, M., Herron, G. S., Wolff, K. and Petzelbauer, P. (2004) IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J. Immunol. 173, 7161-7169.
36. Kirkin, V., Thiele, W., Baumann, P., Mazitschek, R., Rohde, K., Fellbrich, G., Weich, H., Waltenberger, J., Giannis, A. and Sleeman, J. P. (2004) MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo. Int. J. Cancer 112, 986-993.
37. Ristimaki, A., Narko, K., Enholm, B., Joukov, V. and Alitalo, K. (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J. Biol. Chem. 273, 8413-8418.
38. Zhang, Z., Liu, Z. and Meier, K. E. (2006) Lysophosphatidic acid as a mediator for pro-inflammatory agonists in a human corneal epithelial cell line. Am. J. Physiol. Cell. Physiol. 291, C1089-1098.
39. Lin, C. I., Chen, C. N., Chen, J. H. and Lee H. (2006) Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. J. Cell. Biochem. 99, 1216-1232.
40. Geleff, S., Schoppmann, S. F. and Oberhuber, G.. (2003) Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Arch. 442, 231-237.
41. Kerjaschki, D., Regele, H. M., Moosberger, I., Nagy-Bojarski, K., Watschinger, B., Soleiman, A., Birner, P., Krieger, S., Hovorka, A., Silberhumer, G., Laakkonen, P., Petrova, T., Langer, B. and Raab, I. (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15, 603-612.
42. Krzystek-Korpacka, M., Matusiewicz, M., Diakowska, D., Grabowski, K., Blachut, K., Konieczny, D., Kustrzeba-Wojcicka, I., Terlecki, G. and Banas, T. (2008) Elevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas - Implication for clinical evaluation of cancer patient. Cytokine 41, 232-239.
43. Distler, J. H., Hirth, A., Kurowska-Stolarska, M., Gay, R. E., Gay, S. and Distler, O. (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q. J. Nucl. Med. 47, 149-161.
44. Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A.T. and De Bruijn, E. A. (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56, 549-580.
45. Kim, H. S., Shin, H. S., Kwak, H. J., Cho, C. H., Lee, C. O. and Koh, G. Y. (2003) Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3′-kinase in endothelial cell. FASEB J. 17, 318-320.
46. Sini, P., Wyder, L., Schnell, C., O'Reilly, T., Littlewood, A., Brandt, R. Hynes, N. E and Wood, J. (2005) The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade. Clin. Cancer Res. 11, 4521-4532.
47. Michaud-Levesque, J., Demeule, M. and Béliveau R. (2007) In vivo inhibition of angiogenesis by a soluble form of melano-transferrin. Carcinogenesis 28, 280-288.
48. Wu, W., Onn, A., Isobe, T., Itasaka, S., Langley, R. R., Shitani, T., Shibuya, K., Komaki. R,, Ryan. A, J, Fidler, I. J., Herbst, R. S. and O'Reilly, M. S. (2007) Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Mol. Cancer Ther. 6, 471-483.
49. Podgrabinska, S., Braun, P., Velasco, P., Kloos, B., Pepper, M. S. and Skobe, M. (2002) Molecular characterization of lymphatic endothelial cells. Proc. Natl. Acad. Sci. USA 99, 16069-16074.
50. Mancino, A., Mancino, M. G., Glaser, S. S., Alpini, G., Bolognese, A., Izzo, L., Francis, H., Onori, P., Franchitto, A., Ginanni-Corradini, S., Gaudio, E. and Alvaro, D. (2008) Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. Dig. Liver Dis. [Epub ahead of print].
51. Tang, R. F., Wang, S. X., Zhang, F. R., Peng, L., Wang, S. X., Xiao, Y. and Zhang, M. (2005) Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer. Hepatobiliary Pancreat. Dis. Int. 4, 460-463.